Health
Italian COVID-19 vaccine shows strong immune response in mid-stage trial – bdnews24.com
Italy’s hopes of producing its own COVID-19 vaccine were given a boost on Monday when local biotech firm ReiThera said its vaccine…
The vaccine, called GRAd-COV2, induced an antibody response against the SARS-CoV-2 spike protein in over 93 percent of volunteers three weeks after the first dose, reaching 99 percent after the second dose, the company said in a statement.
However, ReiThera…
Continue Reading
-
Noosa News14 hours agoSearch for man who ‘faked death’ slowed by unusual French law
-
General12 hours agoMatildas vs Panama international friendly — live blog and scores from Bunbury
-
Noosa News20 hours agoQueensland Rail retires iconic electric train fleet after more than four decades
-
Business17 hours ago2 ASX 200 large-cap shares that this fundie is cashing in after phenomenal growth